Comparing two contrast dyes for pituitary MRI
Treatments studied
Part of Brain & nervous system, Ear, nose & throat clinical trials.
This trial compares two contrasting dyes (gadopiclenol and gadobutrol) used during pituitary MRI scans to see which one provides clearer images. It is for adults with known or suspected pituitary lesions that disrupt the blood-brain barrier.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man 18 or older, or a woman 55 or older.
- You have a known or suspected pituitary lesion seen on a CT or MRI within the past year.
- You are already scheduled for a contrast-enhanced MRI of the pituitary and agree to a second MRI for the study.
- If you had treatment for the lesion since your last scan, there must still be strong evidence that the lesion remains.
- You are willing and able to give written consent and follow the study procedures.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a newer contrast agent, gadopiclenol, works as well as the standard one for liver scans. It might be an option if you need an MRI to check for liver disease, tumors, or treatment response.
This study tests a new radioactive dye called [18F]GATT-44 to see how well it can show a specific brain protein on a PET scan. It may help researchers better understand brain conditions in the future.
This trial compares two different dyes (gadopiclenol and gadobutrol) used during MRI scans for people with unexpected kidney or adrenal findings. The goal is to see which dye works better for getting clear images of these areas.
This study tests a new contrast dye used during MRI scans of the brain or spine. It may help doctors see lesions more clearly.
This study looks at whether getting the MRI contrast dye multiple times over 5 years affects body movement and thinking skills. It compares people who had the dye repeatedly with people who have little or no exposure, using brain MRI scans and regular mental and movement testing.
This trial tests a new MRI contrast dye (gadopiclenol) to see if it works as well as the standard dye for finding blocked or narrowed blood vessels. If you have symptoms of vascular disease, you may be able to join and help compare the two dyes.
Hear when a new Contrast Enhanced Images vs. Non-contrast Images trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.